Silverback Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $11M | 1.0M | 10.55 |
| 2024-09-30 | $1.6M | 110k | 14.50 |
| 2024-06-30 | $553k | 65k | 8.51 |
| 2024-03-31 | $1.1M | 104k | 10.22 |
| 2023-12-31 | $9.5k | 1.7k | 5.48 |
| 2023-03-31 | $19k | 2.9k | 6.51 |
| 2022-09-30 | $0 | 12 | 0.00 |
| 2022-06-30 | $2.0k | 502 | 3.98 |
| 2022-03-31 | $2.9k | 513 | 5.75 |
| 2021-12-31 | $525k | 79k | 6.66 |
| 2021-09-30 | $137k | 14k | 9.98 |
| 2021-06-30 | $5.0k | 175 | 28.57 |
| 2021-03-31 | $154k | 3.5k | 43.52 |
| 2020-12-31 | $4.0k | 93 | 43.01 |